AEterna Zentaris Inc. (AEZS)

[chmcnfunds]

More AEZS news out today:

Aeterna Zentaris to Present at Two Upcoming Investment Conferences in the United States

By: PR Newswire
Sep. 1, 2011 07:30 AM

QUÉBEC CITY, Sept. 1, 2011 /PRNewswire/ -

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its President and CEO, Juergen Engel, Ph.D., will make corporate presentations at the following investment conferences:

Wednesday, September 7, 2011
Stifel Nicolaus 2011 Healthcare Conference
2:05 p.m. (Eastern Time)
Phillips Room, Four Seasons Hotel, Boston

Tuesday, September 13, 2011
Rodman & Renshaw Annual Global Investment Conference
10:25 a.m. (Eastern Time)
Starlight Center, Waldorf-Astoria Hotel, New York

A live webcast of the presentations will be available on Aeterna Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, prostate and bladder cancer. The Company's innovative approach of "personalized medicine" means tailoring treatments to a patient's specific condition and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn from its proprietary discovery unit providing the Company with constant and long-term access to state-of-the-art therapeutic options. For more information please visit www.aezsinc.com.

SOURCE AETERNA ZENTARIS INC.
________________________________________________________________
http://www.sys-con.com/node/1965148

AEZS